expert
rev
mol
diagn
emerg
new
viral
infect
necessari
set
new
targetspecif
assay
base
exist
molecular
techniqu
realtim
pcr
quickli
possibl
without
diagnost
tool
geograph
spread
new
infect
followup
diseas
outbreak
analysi
pathogenesi
diseas
possibl
therefor
genom
inform
emerg
pathogen
diagnost
protocol
standard
allow
qualiti
control
need
avail
day
implement
good
qualiti
experienc
laboratori
suitabl
infrastructur
establish
inhous
assay
even
though
molecular
tool
avail
quickli
challeng
still
remain
sampl
type
select
proper
diagnost
valu
coronavirus
cov
known
caus
endem
respiratori
infect
cov
well
epidem
diseas
experienc
emerg
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
research
follow
sar
outbreak
led
identif
addit
human
coronavirus
notion
sever
root
anim
world
therefor
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
trigger
fast
respons
given
concern
potenti
spread
primari
mode
transmiss
respiratori
infect
potenti
transmit
quickli
stress
need
rapid
accur
diagnost
diagnos
patient
track
contact
assay
prefer
embed
exist
diagnost
panel
spectrum
pathogen
caus
respiratori
tract
infect
quit
broad
clinic
syndrom
overlap
optim
diagnosi
emerg
infecti
diseas
requir
sever
step
valid
molecular
diagnost
assay
qualiti
control
system
imbed
routin
workflow
ensur
proper
qualiti
perform
assay
knowledg
kinet
infect
patient
order
abl
interpret
result
posit
particularli
neg
result
signific
standard
control
panel
nucleic
acid
test
provis
time
reliabl
diagnost
great
import
determin
rule
caus
ill
guid
treatment
patient
monitor
cours
infect
outbreak
discoveri
merscov
molecular
diagnost
protocol
distribut
quickli
implement
laboratori
across
world
provid
much
need
initi
outbreak
support
emerg
diseas
qualiti
perform
pcr
may
vari
clinic
valid
requir
suffici
data
correctli
sampl
patient
order
allow
robust
interpret
diagnost
result
addit
assay
standard
may
challeng
due
lack
standard
control
materi
use
reagent
differ
perform
sensit
mismatch
accept
inhibit
therefor
import
provid
posit
standard
materi
allow
diagnost
laboratori
evalu
molecular
diagnost
assay
establish
laboratori
case
two
coronavirus
immedi
two
standard
materi
prepar
provid
laboratori
consist
runoff
transcript
recombin
plasmid
design
pcr
length
partial
upe
merscov
genom
respect
univers
bonn
european
viru
archiv
eva
high
titer
inactiv
merscov
viru
prepar
european
network
import
viral
diseas
enivd
standard
pro
con
regard
applic
assay
evalu
runoff
transcript
plasmid
construct
easi
produc
noninfecti
stabl
concentr
measur
easili
howev
runoff
transcript
plasmid
repres
small
part
entir
viru
genom
specif
target
sequenc
region
make
laboratori
less
flexibl
designingus
inhous
design
realtim
pcr
runoff
transcript
plasmid
use
monitor
qualiti
nucleic
acid
extract
condit
ad
extract
pcrcontrol
final
step
increas
chanc
fals
posit
assay
result
caus
contamin
altern
prepar
viru
standard
requir
propag
infecti
viru
suscept
cellcultur
level
biosafeti
condit
high
titer
supernat
infect
cellcultur
properli
inactiv
stabil
freezedri
method
inactiv
standard
compris
whole
virusgenom
use
numer
investig
sinc
latter
standard
prepar
handl
exact
way
patient
sampl
entir
pcr
method
includ
nucleic
acid
extract
evalu
prevent
carryov
contamin
clinic
sampl
allow
laboratori
assess
broad
spectrum
analyt
paramet
sensit
robust
correct
genotyp
inclus
specif
assay
detect
close
relat
pathogen
even
process
differ
type
patient
sampl
blood
serum
sputum
respiratori
fluid
bronchoalveolar
lavag
fece
urin
diagnost
materi
could
use
materi
spike
inactiv
viru
diagnost
laboratori
implement
novel
molecular
diagnost
assay
routin
workflow
particip
extern
qualiti
assur
eqa
studi
help
exercis
evalu
perform
assay
therefor
respons
merscov
emerg
enivd
prepar
set
sampl
differ
concentr
merscov
four
common
human
coronavirus
two
neg
control
inactiv
freezedri
merscov
standard
pretest
two
expert
laboratori
distribut
interest
laboratori
request
laboratori
receiv
eqa
sampl
laboratori
send
back
result
allow
particip
quick
evalu
result
summari
overview
tabl
data
set
receiv
send
back
anonym
code
particip
laboratori
allow
laboratori
interpret
find
real
sampl
content
result
diagnost
laboratori
regard
sensit
specif
merscov
eqa
panel
result
show
success
quick
share
molecular
diagnost
protocol
sinc
least
laboratori
use
first
assay
upe
publish
merscov
recommend
screen
assay
also
overal
sensit
result
good
sinc
particip
score
award
point
howev
particip
score
less
indic
lower
sensit
specif
alert
need
improv
diagnost
procedur
either
person
train
chang
assay
procedur
merscov
eqa
panel
show
high
percentag
fals
posit
result
either
neg
control
sampl
contain
common
nonmer
human
coronavirus
show
import
exercis
optim
diagnost
method
impli
assess
analyt
paramet
describ
certainli
new
emerg
pathogen
one
assum
sampl
condit
close
relat
pathogen
merscov
tropism
differ
endem
human
coronavirus
target
cell
lower
respiratori
tract
observ
also
made
avian
influenza
virus
therefor
recommend
sampl
broad
spectrum
sampl
type
pathogenesi
kinet
shed
unknown
also
case
merscov
upper
respiratori
tract
sampl
shown
suitabl
materi
type
suspect
patient
diagnos
infect
type
includ
noninvas
sampl
lower
respiratori
tract
sampl
eg
throat
swab
sputum
trachea
aspir
higher
diagnost
signific
merscov
rna
could
also
detect
serum
urin
fece
diagnost
signific
find
suffici
evalu
practic
use
due
lower
respiratori
tract
tropism
mer
cov
molecular
diagnost
assay
low
detect
limit
need
confirm
evalu
monitor
suspect
merscov
patient
sinc
viru
concentr
upper
respiratori
tract
sampl
may
near
detect
limit
assay
addit
triag
patient
crucial
sinc
differenti
diagnosi
respiratori
infect
broad
target
diagnost
requir
care
evalu
patient
histori
ask
right
question
regard
travel
histori
anim
contact
behavior
medic
treatment
includ
vaccin
allerg
reaction
etc
addit
complex
transmiss
emerg
pathogen
result
inform
public
health
measur
implement
case
confirm
merscov
infect
scale
case
rule
latter
done
care
clinic
diagnost
evalu
conclus
emerg
new
viru
infect
requir
fast
targetori
approach
allow
clinician
quick
evalu
clinic
case
patient
respiratori
infect
consid
broad
spectrum
respiratori
pathogen
even
implement
new
inhous
assay
occur
immedi
proper
assay
evalu
requir
support
expert
laboratori
sinc
posit
control
mostli
miss
gener
exchang
materi
method
laboratori
recent
outbreak
possibl
increas
capac
diagnost
laboratori
diagnos
new
threat
agent
short
time
hope
remain
futur
emerg
financi
compet
interest
disclosur
